Suicide Risk From Weight-Loss Drugs Prompts More Questions
The European Union’s drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co.
2023-12-02 06:00
Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies
By Patrick Wingrove (Reuters) -Novo Nordisk said on Thursday it sued one compounding pharmacy and refiled a lawsuit against another
2023-12-01 15:56
Altimmune Jumps 66% After Positive Results for Its Obesity Drug
Altimmune Inc. jumped as much as 66% in late trading after the biotech company reported results from a
2023-12-01 07:24
Long-Time Novo Bull Slashes Stake Citing Weight-Loss Drug Hype
A top-performing European fund manager is calling time on “hype” around weight-loss drugs that has sent Novo Nordisk
2023-11-27 16:47
Ozempic Maker Novo Nordisk Invests $2.3 Billion in France Site
Novo Nordisk A/S plans to invest €2.1 billion ($2.3 billion) to expand production in France as it works
2023-11-24 02:00
Macron to unveil 2.1 billion eur Novo Nordisk pharma investment in France
PARIS French President Emmanuel Macron will on Thursday inaugurate a 2.1 billion euro ($2.3 billion) investment by Danish
2023-11-23 13:25
New ETF Tracks Developers of Obesity Drugs Amid Ozempic Hype
A niche issuer is launching a biotechnology exchange-traded fund whose key holdings include firms benefiting from the hype
2023-11-21 20:50
Novo Nordisk Staff Get Free Wegovy As a Perk If They Need It
If you’re a Novo Nordisk A/S employee with obesity, you will have access to a unique company perk:
2023-11-16 00:27
Germany Mulls Obesity Drug Export Ban as EU Confronts Shortage
Germany is considering an export ban on Novo Nordisk A/S’s blockbuster weight-loss drugs as European countries try to
2023-11-15 18:55
Novo Shares Rise After Wegovy Demonstrates Heart Benefit in Trial
Novo Nordisk A/S shares surged after a key study backed the use of Wegovy, its blockbuster weight-loss drug,
2023-11-13 17:19
Wegovy's heart benefits due to more than weight loss, Novo says
By Patrick Wingrove PHILADELPHIA (Reuters) -Novo Nordisk on Saturday said the heart protective benefits of its wildly popular Wegovy obesity
2023-11-12 22:49
Wegovy Study Bolsters Use In Patients With Obesity and Heart Disease
Novo Nordisk A/S unveiled details from a closely watched study that support use of Wegovy, its blockbuster weight-loss
2023-11-11 21:59